LeadCare II® CLIA-Waived LeadCare® II Point-of-Care system

RNA Medical is a division of Bionostics, Inc. - maker of Magellans LeadCare II quality control materials. RNA Medical representatives are factory trained distributors of the LeadCare II analyzer, test kit and other Magellan products, and are available for demonstrations and reimbursement information assistance. The worlds only CLIA-waived blood-lead analyzer, LeadCare II improves clinical outcomes and is ideal for the physician or pediatric office, health clinic, Point-of-Care Testing, outreach screening programs and veterinary applications. No other system offers the simplicity, accuracy, and immediacy of the LeadCare II. Safe, fast, easy, and inexpensive to use, Magellan developed LeadCare II with a grant from the U.S. Centers for Disease Control. No more waiting days for expensive lab analysis, or worrying about losing track of a child that needs follow-up care. LeadCare II delivers quantitative lead levels equivalent to those reported by outside laboratories in just three minutes. It improves patient care by providing on-the-spot results, cuts your staffs result-tracking and administrative time, and qualifies for reimbursement as a quantitative blood lead test (CPT code: 83655). The LeadCare II Analyzer Kit contains the Analyzer and training materials.